Voya Investment Management LLC Neurocrine Biosciences Inc Transaction History

Voya Investment Management LLC

  • $85.7 Billion
  • Q2 2024

A detailed history of Voya Investment Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 151,481 shares of NBIX stock, worth $19 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
151,481
Previous 148,983 1.68%
Holding current value
$19 Million
Previous $20.5 Million 1.49%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $326,888 - $357,688
2,498 Added 1.68%
151,481 $20.9 Million
Q1 2024

May 15, 2024
BUY
$130.4 - $143.74 $1.86 Million - $2.05 Million
14,237 Added 10.57%
148,983 $20.5 Million
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $4.65 Million - $5.82 Million
-43,843 Reduced 24.55%
134,746 $17.8 Million
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $733,732 - $913,848
7,804 Added 4.57%
178,589 $20.1 Million
Q2 2023

Aug 14, 2023
BUY
$89.53 - $104.87 $474,240 - $555,496
5,297 Added 3.2%
170,785 $16.1 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $346,042 - $452,344
3,677 Added 2.27%
165,488 $16.8 Million
Q4 2022

Feb 14, 2023
BUY
$106.72 - $127.06 $3.92 Million - $4.67 Million
36,761 Added 29.4%
161,811 $19.3 Million
Q3 2022

Mar 03, 2023
SELL
$92.03 - $107.81 $3.38 Million - $3.96 Million
-36,761 Reduced 22.72%
125,050 $13.3 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $4.09 Million - $4.79 Million
44,388 Added 55.03%
125,050 $13.3 Million
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $709,318 - $936,555
9,359 Added 13.13%
80,662 $7.86 Million
Q1 2022

May 16, 2022
BUY
$72.45 - $94.81 $572,427 - $749,093
7,901 Added 12.46%
71,303 $6.69 Million
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $1.92 Million - $2.56 Million
24,140 Added 61.48%
63,402 $5.4 Million
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $78,423 - $90,117
-910 Reduced 2.27%
39,262 $3.77 Million
Q2 2021

Aug 16, 2021
BUY
$89.43 - $102.27 $843,324 - $964,406
9,430 Added 30.67%
40,172 $3.91 Million
Q1 2021

May 17, 2021
SELL
$87.57 - $119.4 $149,481 - $203,815
-1,707 Reduced 5.26%
30,742 $2.99 Million
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $145,400 - $181,236
-1,673 Reduced 4.9%
32,449 $3.11 Million
Q3 2020

Nov 16, 2020
SELL
$96.16 - $135.15 $131,835 - $185,290
-1,371 Reduced 3.86%
34,122 $3.28 Million
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $240,379 - $368,267
2,825 Added 8.65%
35,493 $4.33 Million
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $61,214 - $92,714
-815 Reduced 2.43%
32,668 $2.83 Million
Q4 2019

Feb 14, 2020
SELL
$86.8 - $118.57 $999,328 - $1.37 Million
-11,513 Reduced 25.59%
33,483 $3.6 Million
Q3 2019

Nov 14, 2019
SELL
$83.82 - $101.5 $467,547 - $566,167
-5,578 Reduced 11.03%
44,996 $4.06 Million
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $39,732 - $50,198
550 Added 1.1%
50,574 $4.27 Million
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $810,164 - $1.07 Million
11,689 Added 30.49%
50,024 $4.41 Million
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $1.06 Million - $1.93 Million
-15,508 Reduced 28.8%
38,335 $2.74 Million
Q3 2018

Nov 14, 2018
BUY
$98.88 - $125.85 $50,132 - $63,805
507 Added 0.95%
53,843 $6.62 Million
Q2 2018

Aug 14, 2018
SELL
$75.3 - $105.99 $329,889 - $464,342
-4,381 Reduced 7.59%
53,336 $5.24 Million
Q1 2018

May 15, 2018
BUY
$75.88 - $92.43 $86,047 - $104,815
1,134 Added 2.0%
57,717 $4.79 Million
Q4 2017

Feb 14, 2018
BUY
$58.53 - $77.59 $1.09 Million - $1.45 Million
18,707 Added 49.39%
56,583 $4.39 Million
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $1.82 Million - $2.32 Million
37,876
37,876 $2.32 Million

Others Institutions Holding NBIX

# of Institutions
629
Shares Held
94.2M
Call Options Held
692K
Put Options Held
406K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email